Novel Intranasal Influenza-Vectored Vaccine Corfluvec Provides Protection Against Influenza and COVID-19, Mitigating SARS-CoV-2-Induced Lung Vascular Damage

<b>Introduction</b>: The development of bivalent mucosal vaccines capable of providing protection against both influenza and SARS-CoV-2 is a major public health focus. While most COVID-19 vaccines target the spike (S) protein, the highly conserved nucleocapsid (N) protein represents a strategic targ...

Descripció completa

Dades bibliogràfiques

Autors principals:	Marina Stukova, Anna-Polina Shurygina, Arman Muzhikyan, Ekaterina Romanovskaya-Romanko, Zhanna Buzitskaya, Marina Shuklina, Anastasia Pulkina, Daria Shamakova, Kirill Kryshen, Mariia Sergeeva, Dmitriy Lioznov
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2026-08-01
Col·lecció:	Vaccines
Matèries:	SARS-CoV-2 influenza influenza-vectored vaccine nucleocapsid protein mucosal immunization vascular and endothelial integrity
Accés en línia:	https://www.mdpi.com/2076-393X/14/8/684
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!